Breast Neoplasms
Showing NaN - NaN of 29
Breast Tumors Trial in United States (endocrine therapy alone without radiotherapy)
Active, not recruiting
- Breast Neoplasms
- endocrine therapy alone without radiotherapy
-
Stanford, California
- +12 more
Dec 20, 2022
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Tumors, Tumor Metastasis Trial in Worldwide (Imlunestrant, Exemestane, Fulvestrant)
Recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- Imlunestrant
- +3 more
-
Chandler, Arizona
- +238 more
Aug 17, 2022
Breast Tumors, Malignant Tumor of Breast Trial in Dallas (Trastuzumab, Ibrutinib 560 mg, Ibrutinib 840 mg)
Recruiting
- Breast Neoplasms
- Malignant Neoplasm of Breast
- Trastuzumab
- +3 more
-
Dallas, Texas10 sites incl TX, WA, VA, and NV
May 16, 2022
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)
Completed
- Breast Neoplasms
- +2 more
-
Flagstaff, Arizona
- +361 more
Dec 20, 2021
Breast Tumors Trial in Spain, United States (Fulvestrant, Sapanisertib)
Completed
- Breast Neoplasms
-
Mobile, Alabama
- +52 more
Nov 20, 2020
Colonic Tumors, Breast Tumors, Lung Tumors Trial in Dallas (Educational DVD)
Completed
- Colonic Neoplasms
- +2 more
- Educational DVD
-
Dallas, TexasParkland Hospital
Aug 11, 2020
Diagnostic Improvement Gained Through Optimization of MR Methods
Completed
- Breast Neoplasms
- 3 Tesla Magnetic Resonance Imaging
-
Dallas, TexasUT Southwestern Medical Center - Advanced Imaging Research Cente
Oct 17, 2017
Breast Tumors Trial in Worldwide (CP-751,871, exemestane, Fulvestrant)
Breast Tumors Trial in United States (exemestane (Aromasin), tamoxifen + exemestane)
Completed
- Breast Neoplasms
- exemestane (Aromasin)
- tamoxifen + exemestane
-
Bessemer, Alabama
- +178 more
Oct 6, 2015
Breast Tumors Trial in Worldwide (Tamoxifen, Exemestane)
Completed
- Breast Neoplasms
-
Birmingham, Alabama
- +379 more
Apr 21, 2014
Breast Tumors, Osteoporosis Trial in Puerto Rico, United States (Zoledronic Acid, Letrozole)
Completed
- Breast Neoplasms
- Osteoporosis
- Zoledronic Acid
- Letrozole
-
Springdale, Arkansas
- +43 more
Feb 21, 2014
Breast Tumors Trial in Worldwide (SU011248, Chemotherapy)
Completed
- Breast Neoplasms
-
Corona, California
- +112 more
Jul 2, 2012
Breast Tumors, Tumor Metastasis Trial in Canada, United States (Temsirolimus (CCI-779) for 34 months, Letrozole for 34 months)
Terminated
- Breast Neoplasms
- Neoplasm Metastasis
- Temsirolimus (CCI-779) for 34 months
- Letrozole for 34 months
-
Hoover, Alabama
- +128 more
Nov 7, 2011
OSNA Breast Cancer System to Test Sentinel Lymph Nodes From
Completed
- Breast Neoplasms
- Breast Diseases
- OSNA Breast Cancer System
-
Santa Monica, California
- +10 more
Jun 2, 2010
Breast Tumors Trial in Worldwide (Exemestane, Celecoxib + Exemestane)
Breast Cancer, Breast Tumors, Cancer of the Breast Trial in Worldwide (gemcitabine, docetaxel, capecitabine)
Breast Cancer, Breast Tumors Trial in Puerto Rico, United States (Pemetrexed, Gemcitabine)
Completed
- Breast Cancer
- Breast Neoplasms
-
Aurora, Colorado
- +6 more
May 12, 2009